| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| - | - | 780 | ₹0.95 5.55% | 17,050144.44% |
| - | - | 800 | ₹1.2 -11.11% | 42,6257.84% |
| - | - | 820 | ₹2.5 0% | 7750% |
| 1,5500% | ₹89.05 0% | 830 | ₹2.5 0% | 7750% |
| - | - | 840 | ₹2.35 -2.08% | 8,52510% |
| 5,4250% | ₹69 0% | 850 | ₹2.95 -4.83% | 80,600-2.80% |
| 00% | ₹60 0% | 860 | ₹4 0% | 10,0750% |
| - | - | 870 | ₹5.25 0% | 13,9500% |
| 1,5500% | ₹48 -11.11% | 880 | ₹6.6 -6.38% | 92,22536.78% |
| - | - | 890 | ₹8.8 1.14% | 24,8000% |
| 2,35,600-0.32% | ₹33.2 -9.28% | 900 | ₹12.35 5.1% | 3,33,2503.36% |
| 90,6753.53% | ₹28.45 -3.55% | 910 | ₹15.65 3.98% | 1,18,5754.08% |
| 1,58,8757.32% | ₹21.5 -10.6% | 920 | ₹19.3 -1.53% | 1,48,8002.67% |
| 82,1509.27% | ₹16.8 -11.34% | 930 | ₹24.15 -2.02% | 20,150-3.70% |
| 59,675-1.28% | ₹13.3 -10.73% | 940 | ₹28.5 0% | 10,8500% |
| 2,52,6508.66% | ₹10.05 -12.22% | 950 | ₹37.2 0% | 1,39,5000% |
| 82,1500% | ₹7.9 -8.67% | 960 | ₹45.1 7.38% | 11,62515.38% |
| 7750% | ₹38.9 0% | 970 | ₹58.05 0% | 7750% |
| 63,550127.77% | ₹4.15 -16.16% | 980 | ₹70 0% | 7750% |
| 9,300-20% | ₹3.4 -6.84% | 990 | - | - |
| 1,67,40015.50% | ₹2.4 -15.78% | 1,000 | ₹73.35 0% | 22,4750% |
| 15,5000% | ₹1.6 -3.03% | 1,020 | - | - |
| 9,30071.42% | ₹0.95 -93.66% | 1,040 | - | - |
| - | - | 1,050 | ₹136.25 0% | 7,7500% |
| 1,5500% | ₹4.9 0% | 1,080 | - | - |
| 4,650200% | ₹0.3 -57.14% | 1,100 | ₹177 0% | 4,6500% |
Fortis will take charge of the entire operational and financial aspects. Hence, consolidating the hospital's performance within its network.
Operating performance remained strong with EBITDA rising 43% year-on-year to ₹490.4 crore. The EBITDA margin expanded to 22.6%, from 18.4% a year ago.
The tax demand will not affect the company’s financials or operations, it said in a regulatory filing.
Here are some of the stocks that may see significant price movement today: UltraTech Cement, Jio Financial, Avenue Supermarts, etc.
EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.
The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.
Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.
Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
